- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
630
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
630 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
600760 | CN¥46.56 | 0% | 34.5% | CN¥128.3b | CN¥53.90 | PE52.1x | E29.4% | 0.6% | Capital Goods | ||
605499 | CN¥243.15 | 0% | 85.0% | CN¥126.4b | CN¥262.72 | PE40.9x | E25.1% | 0.8% | Food, Beverage & Tobacco | ||
RHM | €764.00 | 5.6% | 133.3% | €32.8b | €769.79 | PE48.4x | E29.9% | 0.7% | Capital Goods | ||
ARES | US$196.52 | 3.4% | 57.8% | US$62.1b | US$197.14 | PE91.8x | E38.4% | 1.9% | Diversified Financials | ||
ONON | US$58.52 | -2.3% | 115.4% | US$19.2b | US$62.47 | PE135.7x | E29.7% | n/a | Consumer Durables | ||
ALNY | US$274.55 | -0.8% | 60.8% | US$35.0b | US$299.74 | PS16.9x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
9992 | HK$92.65 | -1.4% | 405.2% | HK$122.9b | HK$98.09 | PE74.8x | E35.8% | 0.3% | Retail | ||
NVDA | US$116.66 | -1.5% | 68.3% | US$2.9t | US$173.78 | PE45.3x | E21.7% | 0.03% | Semiconductors | ||
NU | US$13.14 | 6.7% | 41.7% | US$63.6b | US$15.06 | PB8.3x | E25.2% | n/a | Banks | ||
MRVL | US$113.56 | 13.2% | 69.4% | US$97.7b | US$129.25 | PS18.3x | E55.6% | 0.2% | Semiconductors | ||
300308 | CN¥114.82 | 0% | 28.7% | CN¥126.8b | CN¥196.50 | PE27.4x | E33.1% | 0.3% | Tech | ||
300502 | CN¥125.77 | 0% | 171.5% | CN¥89.1b | CN¥161.36 | PE46.8x | E36.6% | 0.1% | Tech | ||
BESI | €121.85 | -2.4% | -16.2% | €9.9b | €146.55 | PE54.7x | E25.3% | 1.8% | Semiconductors | ||
A196170 | ₩352,500.00 | -2.6% | 356.0% | ₩18.8t | ₩565,000.00 | PS252.6x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
2345 | NT$726.00 | -4.8% | 32.5% | NT$405.8b | NT$789.38 | PE41.7x | E25.1% | 1.4% | Tech | ||
600989 | CN¥17.53 | 0% | 33.2% | CN¥128.6b | CN¥21.74 | PE20.4x | E38.5% | 1.6% | Materials | ||
ITCI | US$127.19 | -0.02% | 84.3% | US$13.5b | US$128.64 | PS22x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$84.83 | -0.6% | 57.9% | CA$36.5b | CA$73.97 | PE54.3x | E87.6% | 2.6% | Diversified Financials | ||
KSPI | US$95.67 | -1.2% | 5.3% | US$18.1b | US$126.60 | PE9.8x | E20.8% | 6.8% | Diversified Financials | ||
SMCI | US$26.85 | -7.6% | -59.5% | US$16.7b | US$40.79 | PE13x | E24.3% | n/a | Tech | ||
PME | AU$281.86 | 4.8% | 160.3% | AU$29.5b | AU$215.57 | PE355.8x | E22.5% | 0.2% | Healthcare | ||
6669 | NT$2,040.00 | -8.9% | -9.9% | NT$379.1b | NT$3,013.06 | PE19.7x | E24.1% | 2.1% | Tech | ||
BAJFINANCE | ₹8,475.35 | 11.4% | 28.5% | ₹5.2t | ₹8,605.79 | PE32.8x | E23.2% | 0.4% | Diversified Financials | ||
500251 | ₹6,134.85 | 13.4% | 102.7% | ₹2.2t | ₹6,873.05 | PE119.9x | E25.1% | 0.05% | Retail |